青光眼诊断生物标志物的研究进展
本文综述青光眼诊断相关生物标志物的研究进展,从DNA、RNA、蛋白质等方面阐述潜在分子靶标。目前生物标志物样本来自临床已确诊青光眼患者,其改变可能是中晚期青光眼的分子生物学特征,对早期诊断及病理机制阐明是否有帮助仍有待探讨。
要点
- 青光眼病因未明,亟需有效早期诊断方案。
- 已发现的生物标志物样本来自临床确诊青光眼患者,可能反映中晚期特征。
- 需进一步探讨这些标志物对早期诊断及病理机制的价值。
核心结论
- 本文从DNA、RNA、蛋白质等方面阐述可帮助青光眼诊断的潜在分子靶标,并讨论进一步研究路径与临床应用前景。
研究设计与样本
- 本文为综述,从DNA、RNA和蛋白质方面阐述青光眼诊断的潜在分子靶标。
主要发现
- 近年发现众多青光眼相关生物标志物,一系列研究正在开展以明确其特异性和敏感性。
- 目前生物标志物样本来自临床已确诊青光眼患者,其改变可能是中晚期青光眼的分子生物学特征。
临床怎么用
- 原文未据此给出推荐。
局限性
- 目前获得的生物标志物样本来自临床已确诊为青光眼的患者,其改变可能是中晚期青光眼的分子生物学特征。
- 这些生物标志物对青光眼早期诊断及其病理机制的阐明是否有帮助仍有待探讨。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glaucoma is a serious irreversible blinding disease. The pathogenesis is still unknown, and the diagnosis and treatment effect is not good. An effective early diagnosis method is urgently needed. In recent years, a number of glaucoma-related biomarkers have been discovered. In order to promote clinical application of these biomarkers, a series of studies are actively carried out to clarify specificity and sensitivity of these molecules, to verify the criteria by clinical randomized controlled trials, and to provide large sample data by multi-center clinical trials. However, the samples of these biomarkers are provided by patients who have been diagnosed with glaucoma by clinical examinations. The differences may represent the molecular features of middle-stage and advanced glaucoma. Whether they are helpful for early diagnosis and the exploration of pathological mechanisms should be further investigated. This article describes the potential molecular targets that can help in diagnosis of glaucoma from the aspects of DNA, RNA and protein, and discusses further research pathways and clinical application prospects. It is hoped to explore the effective molecular marker for early diagnosis of glaucoma. (Chin J Ophthalmol, 2021, 57: 707-711). 青光眼是一类严重的不可逆性致盲眼病,至今病因未明,诊疗效果不佳,亟需有效的早期诊断方案。近年,众多青光眼相关生物标志物被发现,为促进临床应用一系列研究正在积极开展。但目前获得的生物标志物样本来自临床已确诊为青光眼的患者,即这些生物标志物的改变可能是中晚期青光眼的分子生物学特征,对青光眼的早期诊断及其病理机制的阐明是否有帮助仍有待探讨。本文从DNA、RNA、蛋白质等方面阐述可以帮助青光眼诊断的潜在分子靶标,并讨论其进一步的研究路径,希望从分子水平为青光眼的早期诊断探寻靶点。(中华眼科杂志,2021,57:707-711).
引用
- Zhang JX, Zhang SQ, Yuan HP, et al. [Research progress in biomarkers for diagnosis of glaucoma]. Zhonghua Yan Ke Za Zhi. 2021. PMID: 34865410. doi:10.3760/cma.j.cn112142-20210331-00151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。